Gene · 8991
Papers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,273
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. | Cancer Med | 2023 | 37606338 | PubTator, text mining | PubMed |
| Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia. | BMC Psychiatry | 2023 | 37605121 | PubTator, text mining | PubMed |
| MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. | Cancer Cell Int | 2023 | 37587481 | PubTator, text mining | PubMed |
| Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer. | World J Clin Cases | 2023 | 37584004 | PubTator, text mining | PubMed |
| Impact of BMI z-score on left ventricular mechanics in adolescent girls. | Front Pediatr | 2023 | 37565247 | PubTator, text mining | PubMed |
Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting: study protocol for a randomised controlled trial targeting type 2 diabetes individuals with non-ideal glycaemic values (Telemechron study). | Trials | 2023 | 37563665 | PubTator, text mining | PubMed |
| Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor. | Nat Cell Biol | 2023 | 37563253 | PubTator, text mining | PubMed |
| Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions. | Ann Surg Oncol | 2023 | 37548833 | PubTator, text mining | PubMed |
| Sensing preferences for prokaryotic solute binding protein families. | Microb Biotechnol | 2023 | 37547952 | PubTator, text mining | PubMed |
| Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. | Signal Transduct Target Ther | 2023 | 37518181 | PubTator, text mining | PubMed |
| Pre-T cell receptor localization and trafficking are independent of its signaling. | J Cell Biol | 2023 | 37516909 | PubTator, text mining | PubMed |
| Hydrogen sulfide-induced post-translational modification as a potential drug target. | Genes Dis | 2023 | 37492730 | PubTator, text mining | PubMed |
| Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis. | Mult Scler J Exp Transl Clin | 2023 | 37483527 | PubTator, text mining | PubMed |
| Soluble Dietary Fibers as Antihyperlipidemic Agents: A Comprehensive Review to Maximize Their Health Benefits. | ACS Omega | 2023 | 37483202 | PubTator, text mining | PubMed |
| N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope. | Cell Commun Signal | 2023 | 37480072 | PubTator, text mining | PubMed |
| Gene expression analysis in recurrent benign paroxysmal positional vertigo: a preliminary study. | Front Neurol | 2023 | 37475735 | PubTator, text mining | PubMed |
| Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic-pharmacodynamic models. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37452622 | PubTator, text mining | PubMed |
| The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer. | Int J Mol Sci | 2023 | 37446063 | PubTator, text mining | PubMed |
| Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models. | Cancers (Basel) | 2023 | 37444459 | PubTator, text mining | PubMed |
| Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults. | Alzheimers Res Ther | 2023 | 37438770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8991/papers?page=10